Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-036720
Filing Date
2025-07-30
Accepted
2025-07-30 16:14:29
Documents
77
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abt-20250630.htm   iXBRL 10-Q 1529305
2 EX-31.1 q2202510qex311.htm EX-31.1 9342
3 EX-31.2 q2202510qex312.htm EX-31.2 9332
4 EX-32.1 q2202510qex321.htm EX-32.1 5105
5 EX-32.2 q2202510qex322.htm EX-32.2 4911
  Complete submission text file 0001628280-25-036720.txt   8912001

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abt-20250630.xsd EX-101.SCH 47611
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abt-20250630_cal.xml EX-101.CAL 64819
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abt-20250630_def.xml EX-101.DEF 283868
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abt-20250630_lab.xml EX-101.LAB 644481
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abt-20250630_pre.xml EX-101.PRE 462647
80 EXTRACTED XBRL INSTANCE DOCUMENT abt-20250630_htm.xml XML 1794037
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-02189 | Film No.: 251167217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)